Apoptosis-associated proteins in oral lymphomas from HIV-positive patients

Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics

Volumn 86, Issue 2, 1998, Pages 196-202

  Regezi, Joseph A ^a   McMillan, Alex ^b   Dekker, Nusi ^a   Daniels, Troy E ^a   Silverman Jr , Sol ^a   Schoelch, Michael ^a,c   Ziober, Barry L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c US Navy   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BAK1 PROTEIN, HUMAN; BAX PROTEIN, HUMAN; BCL2L1 PROTEIN, HUMAN; BHRF1 PROTEIN, HUMAN HERPESVIRUS 4; MDM2 PROTEIN, HUMAN; MEMBRANE PROTEIN; NUCLEAR PROTEIN; ONCOPROTEIN; PROTEIN; PROTEIN BAK; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL X; PROTEIN MDM2; PROTEIN P53; TUMOR PROTEIN; VIRUS PROTEIN;

ADOLESCENT; ADULT; AGED; APOPTOSIS; ARTICLE; B CELL LYMPHOMA; CHEMISTRY; CHILD; COMPARATIVE STUDY; DISEASE COURSE; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERPLASIA; LYMPH NODE; MALE; MIDDLE AGED; MOUTH TUMOR; PATHOLOGY; SERODIAGNOSIS;

ADOLESCENT; ADULT; AGED; APOPTOSIS; BCL-2 HOMOLOGOUS ANTAGONIST-KILLER PROTEIN; BCL-2-ASSOCIATED X PROTEIN; BCL-X PROTEIN; CHILD; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HIV SERONEGATIVITY; HIV SEROPOSITIVITY; HUMANS; HYPERPLASIA; LYMPH NODES; LYMPHOMA, AIDS-RELATED; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM PROTEINS; NUCLEAR PROTEINS; PROTEINS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; PROTO-ONCOGENE PROTEINS C-MDM2; TUMOR SUPPRESSOR PROTEIN P53; VIRAL PROTEINS;

EID: 0032132516     PISSN: 10792104     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1079-2104(98)90125-1     Document Type: Article

References (55)

1. Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics, 1997. CA Cancer J Clin 1997;47:5-27.
2. Economopoulos T, Asprou N, Stathakis N, Papageorgio E, Dervenoulas J, Xanthaki K, et al. Primary extrariodal non-Hodgkin's lymphoma in adults: clinicopathological and survival characteristics. Leukemia Lymphoma 1996;21:131-6.
3. Hamilton-Dutoit SJ, Pallesen G, Franzmann MB, et al. AIDS-related lymphoma. Am J Pathol 1991;138:149-63.
4. Ioachim HL, Dorsett B, Cronin W, Maya M, Wahl S. Acquired immunodeficiency syndrome-associated lymphomas: clinical, pathologic, immunologic, and viral characteristics of 111 cases. Hum Pathol 1991;22:659-73.
5. Serraino D, Pezzotti P, Dorrucci M, Alliegro MB, Sinicco A, Rezza G. Cancer incidence in a cohort of human immunodeficiency virus seroconverters. Cancer 1997;79:1004-8.
6. Ziegler JL, Beckstead JA, Volberding PA, Abrams DI, Levine AM, Lukes RJ, et al. Non-Hodgkin's lymphoma in 90 homosexual men. N Engl J Med 1984;311:565-70.
7. Fukuda Y, Ishida T, Fujimoto M, Ueda T, Aozasa K. Malignant lymphoma of the oral cavity: clinicopathologic analysis of 20 cases. J Oral Pathol 1987;16:8-12.
8. Soderholm AL, Lindqvist C, Heikinheimo K, Forssell K, Happonen RP. Non-Hodgkin's lymphomas presenting through oral symptoms. Int J Oral Maxillofac Surg 1990;19:131-4.
9. Carbone A, Vaccher E, Barzan L, Gloghini A, Volpe R, De Re V, et al. Head and neck lymphomas associated with human immunodeficiency virus infection. Arch Otolaryngol Head Neck Surg 1995;121:210-8.
10. Green TL, Eversole LR. Oral lymphomas in HIV-infected patients: association with Epstein-Barr virus. Oral Surg Oral Med Oral Pathol 1989;67:437-42.
11. Handlers JP, Howell RE, Abrams AM, Melrose RJ. Extranodal oral lymphoma, I: a morphologic and immunoperoxidase study of 34 cases. Oral Surg Oral Med Oral Pathol 1986;61:362-7.
12. Lozada-Nur F, De Sanz S, Silverman S, Miranda C, Regezi J. Intraoral non-Hodgkin's lymphoma in seven patients with acquired immunodeficiency syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1996;82:173-8.
13. Regezi JA, Zarbo RJ, Stewart JCB. Extranodal oral lymphomas: histologic subtypes and immunophenotypes (in routinely processed tissue). Oral Surg Oral Med Oral Pathol 1991;72:702-8.
14. Raphael M, Gentilhomme O, Tuillez M, Byron PA, Diebold J. Histopathologic features of high-grade non-Hodgkin's lymphomas in acquired immunodeficiency syndrome. Arch Pathol Lab Med 1991;115:15-20.
15. Majno G, Joris I. Apoptosis, oncosis, and necrosis: an overview of cell death. Am J Pathol 1995;146:3-15.
16. Payne CM, Bernstein C, Bernstein H. Apoptosis overview emphasizing the role of oxidative stress, DNA damage and signal-transduction pathways. Leukemia Lymphoma 1995;19:43-93.
17. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992;119:493-501.
18. Farber E. Programmed cell death: necrosis versus apoptosis. Mod Pathol 1994;7:605-9.
19. Stellar H. Mechanisms and genes of cellular suicide. Science 1995;267:1445-8.
20. Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science 1995;267:1456-62.
21. Cory S. Regulation of lymphocyte survival by the Bcl-2 gene family. Annu Rev Immunol 1995;13:513-43.
22. Reed JC. Bcl-2 and the regulation of programmed cell death. J Cell Biol 1994;124:1-6.
23. Boise LH, Gonzalez M, Postema CE, Ding L, Lindsten T, Turka LA, et al. Bcl-X, a Bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 1993;74:597-608.
24. L is the major Bcl-x mRNA form expressed during murine development and its product localizes to mitochondria. Development 1994;120:3033-42.
25. Nunez G, Merino R, Grillot D, Gonzalez-Garcia M. Bcl-2 and Bcl-x: regulatory switches for lymphoid death and survival. Immunol Today 1994;15:582-8.
26. Oltvai ZN, Korsmeyer SJ. Checkpoints of dueling dimers foil death wishes. Cell 1994;79:189-92.
27. Oltvai ZN, Milliman Cl, Korsmeyer SJ. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 1993;74:609-19.
28. Chittenden T, Harrington EA, O'Connor R, Flemington C, Lutz RJ, Evan GI, et al. Induction of apoptosis by the Bcl-2 homologue Bak. Nature 1995;374:733-6.
29. Keifer MC, Brauer MJ, Powers VC, Wu JJ, Umanski SR, Tomei LD, et al. Modulation of apoptosis by the widely distributed Bcl-2 homologue Bak. Nature 1995;374:736-9.
30. Reed JC, Zha H, Aime-Sempe C, Takayama S, Wang HG. Structure-function analysis of Bcl-2 family proteins: regulators of programmed cell death. Adv Exp Med Biol 1996;406:99-112.
31. Pezella F, Gatter K. What is the value of Bcl-2 protein detection for histopathologists? Histopathology 1995;26:89-93.
32. Tsujimotoy J, Cossman E, Jaffe E, Croce H. Involvement of the Bcl-2 gene in human follicular lymphoma. Science 1985;228:1440-3.
33. Krajewski S, Bodrug S, Gascoyne R, Berean K, Krajewska M, Reed JC. Immunohistochemical analysis of Mcl-1 and Bcl-2 proteins in normal and neoplastic lymph nodes. Am J Pathol 1994;145:515-25.
34. Schlaifer D, Krajewski S, Galoin S, Rigal-Huguet F, Laurent G, Massip P, et al. Immunodetection of apoptosis-regulating proteins in lymphomas from patients with and without human immunodeficiency virus infections. Am J Pathol 1996;149:177-85.
35. Takahashi H, Kawazoe K, Fujita S, Okabe H, Hideshima K, Tsuda N, et al. Expression of Bcl-2 oncogene product in primary non-Hodgkin's malignant lymphoma of the oral cavity. Pathol Res Pract 1996;192:44-53.
36. Miyashita T, Harigai M, Hanada M, Reed JC. Identification of a p53-dependent negative response element in the bcl-2 gene. Cancer Res 1994;54:3131-5.
37. Miyashita T, Krajewski S, Krajewska M, Wang HG, Lin HK, Liebermann DA, et al. Tumor suppressor p53 is a regulator of Bcl-2 and bax gene expression in vitro and in vivo. Oncogene 1994;9:1799-805.
38. Piris MA, Villuendas R, Martinez JC, Sanchez-Beato M, Orradre JL, Mateo MS, et al. p53 expression in non-Hodgkin's lymphomas: a marker of p53 inactivation? Leukemia Lymphoma 1995;17:35-42.
39. Szekely L, Selivanova G, Magnusson K, Klein G, Wiman K. EBNA-5, an Epstein-Barr virus-encoded nuclear antigen, binds to the retinoblastoma and p53 proteins. Proc Natl Acad Sci U S A 1993;90:5455-9.
40. Zhang Q, Gutsch D, Kenney S. Functional and physical interaction between p53 and BZLF1: implications for Epstein-Barr virus latency. Mol Cell Biol 1994;14:1929-38.
41. Chilosi M, Doglioni C, Menestrina F, Montagna L, Rigo A, Lestani M, et al. Abnormal expression of the p53-binding protein MDM2 in Hodgkin's disease. Blood 1994;84:4295-300.
42. Ladanyi M, Cha C, Lewis R, Jhanwar SC, Huvos AG, Healy JH. MDM2 gene amplification in metastatic osteosarcoma. Cancer Res 1993;53:16-8.
43. Oliner JD, Kinzler KW, Meltzer PS, George DL, Vogelstein B. Amplification of a gene encoding a p53-associated protein in human sarcomas. Nature 1992;358:80-3.
44. Watanabe T, Hotta T, Ichikawa A, Kinoshita T, Nagai H, Uchida T, et al. The MDM2 oncogene overexpression in chronic lymphocytic leukemia and low-grade lymphoma of B-cell origin. Blood 1994;84:3158-65.
45. Villuendas R, Pezzella F, Gatter K, Algara P, Sanchez-Beato M, Martinez P, et al. p21(WAF1/CIP1) and MDM2 expression in non-Hodgkin's lymphoma and their relationship to p53 status: a p53+, MDM2-, p21- immunophenotype associated with missense p53 mutations. J Pathol 1997;181:51-61.
46. Finke J, Lange W, Mertelsmann, Dolken G. Bcl-2 induction is part of the strategy of Epstein-Barr virus. Leukemia Lymphoma 1994;12:413-9.
47. Okan I, Wang Y, Chen F, Hu L, Imreh S, Klein G, et al. The EBV-encoded LMP1 protein inhibits p53-triggered apoptosis but not growth arrest. Oncogene 1995;11:1027-31.
48. Dawson C, Eliopoulos A, Dawson J, Young L. BHRF1, a viral homologue of the bcl-2 oncogene, disturbs epithelial cell differentiation. Oncogene 1995;9:69-77.
49. Hickish T, Robertson D, Clarke P, Hill M, Stefano F, Clarke C, et al. Ultrastructual localization of BHRF1: an Epstein-Barr virus gene product which has homology with bcl-2. Cancer Res 1994;54:2808-11.
50. Tarodi B, Subramanian T, Chinnadurai G. Epstein-Barr virus BHRF1 protein protects against cell death induced by DNA-damaging agents and heterologous viral infection. Virology 1994;201:404-7.
51. Arber DA, Shibata D, Chen YY, Weiss LM. Characterization of the topography of Epstein-Barr virus infection in human immunodeficiency virus-associated lymphoid tissues. Mod Pathol 1992;5:559-66.
52. Chan JCK, Yip TT, Tsang WY. Detection of Epstein-Barr viral RNA in malignant lymphomas of the upper aerodigestive tract. Am J Surg Pathol 1994;18:938-46.
53. Gulley ML, Raab-Traub N. Detection of Epstein-Barr virus in human tissues by molecular genetic techniques. Arch Pathol Lab Med 1993;117:1115-20.
54. Krajewski S, Krajewska M, Ehrmann J, Sikorska M, Lach B, Chatten J, et al. Immunohistochemical analysis of Bcl-2, Bcl-x, Mcl-1, and Bax in tumors of central and peripheral nervous system origin. Am J Pathol 1997;150:805-14.
55. Yin C, Knudson CM, Korsmeyer SJ, Van Dyke T. Bax suppresses tumorigenesis and stimulates apoptosis in vivo. Nature 1997;385:637-40.